larimar
therapeutics
present
morgan
stanley
virtual
annual
global
healthcare
conference
bala
cynwyd
globe
newswire
larimar
therapeutics
nasdaq
lrmr
biotechnology
company
focused
developing
treatments
complex
rare
diseases
today
announced
carole
md
president
chief
executive
officer
participate
fireside
chat
morgan
stanley
virtual
annual
global
healthcare
conference
thursday
september
edt
live
audio
webcast
presentation
accessible
events
presentations
page
investors
section
larimar
website
https
archived
version
webcast
available
website
days
following
event
larimar
therapeutics
larimar
therapeutics
nasdaq
lrmr
biotechnology
company
focused
developing
treatments
complex
rare
diseases
company
lead
compound
currently
evaluated
phase
clinical
program
potential
treatment
friedreich
ataxia
rare
progressive
genetic
disease
larimar
also
plans
use
intracellular
delivery
platform
design
fusion
proteins
target
additional
rare
diseases
characterized
deficiencies
intracellular
bioactive
compounds
information
please
visit
https
investor
contact
john
woolford
westwicke
